Bernhard Hoffmann serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Bernhard Hoffmann has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 18, 2024 involved receiving (via award) 20,000 shares valued at $0.
Bernhard Hoffmann currently holds 162,697 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bernhard Hoffmann has been a net neutral trader of OCUP stock. They have purchased $0 and sold $0 worth of shares.
Bernhard Hoffmann's most recent insider trade was on Jan 18, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.27 |
| Discretionary |
| Jan 10, 2023 | OCUP | $0 | Award | 46,608 | $N/A | Discretionary |
| Nov 5, 2020 | OCUP | $0 | Award | 100,120 | $N/A | Discretionary |